Infos für
Direkt zu
Fakultäten
Christiane Dings
Forschungsgebiet
|
Lebenslauf
Seit 12/2015: Doktorandin in der Klinischen Pharmazie, Externe Doktorandin im Graduiertenprogramm „PharMetrX“, Pharmacometrics & Computational Disease Modelling
12/2015: Approbation zur Apothekerin
05/2015 – 11/2015: Praktisches Jahr und Diplom, University of Iceland, Reykjavík und Universität des Saarlandes, Saarbrücken
11/2014 – 04/2015: Praktisches Jahr, Einhorn-Apotheke, Saarbrücken-Güdingen
04/2014 – 05/2015: Studentische/wissenschaftliche Hilfskraft in der Klinischen Pharmazie
01/2014 – 04/2014: Studentische Hilfskraft bei RpDoc® Solutions GmbH
10/2009 – 09/2014: Studium der Pharmazie, Universität des Saarlandes, Saarbrücken
07/2009: Abitur am Gymnasium am Schloss, Saarbrücken
Publikationen
Manuskripte
Dings C, Selzer D, Bragazzi NL, Möhler E, Wenning M, Gehrke T, Richter E, Nonnenmacher A, Brinkmann F, Rothoeft T, Zemlin M, Lücke T, Lehr T. Effect of vaccinations and school restrictions on the spread of COVID-19 in different age groups in Germany. Infect Dis Model. 2024; 9(4):1250-1264. Dings C, Lehr T, Vojnar B, Gaik C, Koch T, Eberhart LHJ, Huljic-Lankinen S, Murst M, Kreuer S. Population kinetic/pharmacodynamic modelling of the haemodynamic effects of cafedrine/theodrenaline (Akrinor) under general anaesthesia. Br J Clin Pharmacol 2024. doi:10.1111/bcp.16083 Türk D, Scherer N, Selzer D, Dings C, Hanke N, Dallmann R, Schwab M, Timmins P, Nock V, Lehr T. Significant impact of time-of-day variation on metformin pharmacokinetics. Diabetologia 2023. Rothoeft T, Brinkmann F, Maier C, Selzer D, Dings C, Kuehn A, Möhler E, Grote H, Nonnenmacher A, Wenning M, Zemlin M, Richter U, Lehr T, Lücke T. Motivations for adolescent COVID-19 vaccination: A comparative study of adolescent and caregiver perspectives in Germany. Children (Basel). 2023;10(12):1890. Dings C, Meiser P, Holzer F, Flegel M, Selzer D, Nagy E, Mösges R, Klussmann JP, Lehr T. Pharmacometric modeling of the impact of azelastine nasal spray on SARS-CoV-2 viral load and related symptoms in COVID-19 patients. Pharmaceutics 2022;14(10):2059. Dings C, Götz KM, Och K, Sihinevich I, Werthner Q, Smola S, Bliem M, Mahfoud F, Volk T, Kreuer S, Rissland J, Selzer D, Lehr T. Model-based analysis of SARS-CoV-2 infections, hospitalization and outcome in Germany, the federal states and districts. Viruses 2022;14(10):2114. Scherer N, Kurbasic A, Dings C, Mari A, Nock V, Hennige AM, Koivula RW, Laakso M, Siloaho M, McDonald TJ, Pavo I, Giordano GN, Hansen TH, Rutters F, Dekker JM, Jablonka B, Ruetten H, Pearson ER, Franks PW, Lehr T. The impact and correction of analysis delay and variability in storage temperature on the assessment of HbA1c from dried blood spots - an IMI DIRECT Study. Int J Proteom Bioinform 2019;4(1):7-13. Scherer N, Dings C, Böhm M, Laufs U, Lehr T. Alternative treatment regimens with the PCSK9 inhibitors alirocumab and evolocumab: a pharmacokinetic and pharmacodynamic modeling approach. J Clin Pharmacol 2017;57(7):846-54. |
Poster
Dings C, Scherer N, Freijer J, Nock V, Lehr T. Mathematical modeling of glucose, insulin and c-peptide during the OGTT in pre-diabetic subjects: a DIRECT study. 26th Population Approach Group Europe (PAGE) meeting, 2017, Budapest, Hungary. Dings C, Lehr T. Pharmacokinetic/pharmacodynamic modeling of acetylsalicylic acid and its major metabolite salicylic acid. 25th Population Approach Group Europe (PAGE) meeting, 2016, Lisbon, Portugal. Dings C, Schäftlein A, Lehr T. Predicting the impact of oral anticoagulants on the human coagulation pathway using a comprehensive systems pharmacology model. Annual meeting of the German Pharmaceutical Society (DPhG), 2014, Frankfurt (Main), Germany. |
Kontakt
Christiane Dings Klinische Pharmazie T: +49/681/302-70257 |